Philadelphia Institute of Dermatology is a clinical research site located in Fort Washington, Pennsylvania, United States 19034.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Philadelphia Institute of Dermatology has participated in 13 clinical trials.
Therapeutic areas: Psoriasis Vulgaris, Atopic Dermatitis, Papulopustular Rosacea.
Sponsors: LEO Pharma, Galderma R&D, Veloce BioPharma LLC.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Philadelphia Institute of Dermatology has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Philadelphia Institute of Dermatology has 13 clinical trials on record. Their work covers Psoriasis Vulgaris, Atopic Dermatitis, Papulopustular Rosacea.
Yes — Philadelphia Institute of Dermatology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.